From GlobeNewswire:

The Chief Executive Officer of Morphic Therapeutic, Dr. Praveen Tipirneni, has returned to full capacity after a medical leave. The biotechnology company develops oral integrin therapies for chronic diseases and will present at the 42nd Annual J.P. Morgan Healthcare Conference. View the live webcast on Wednesday, January 10th, or an archived replay following the conference on their website. For more information, visit www.morphictx.com. Contact Morphic Therapeutics at [email protected] or 617.686.1718.



Read more: Morphic to Present at the 42nd Annual J.P. Morgan